Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation

Neoplasia

Volumn 3, Issue 6, 2001, Pages 527-534

  Vordermark, D ^a   Shibata, T ^a   Brown, J M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosarcoma; Green fluorescent protein; Hypoxia; Reoxygenation; Transfection

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN;

ARTICLE; CHROMATOPHORE; CONTROLLED STUDY; FIBROSARCOMA; FLOW CYTOMETRY; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; TISSUE OXYGENATION; WESTERN BLOTTING;

EID: 0035215945     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900192     Document Type: Article

References (29)

1. Primary structure of the Aequorea victoria green fluorescent protein
2. Green fluorescent protein as a marker for gene expression
3. The green fluorescent protein
4. Wavelength mutations and posttranslational autoxidation of green fluorescent protein
5. Chromophore formation in green fluorescent protein
6. Reperfusion injury in livers due to gentle in situ organ manipulation during harvest involves hypoxia and free radicals
7. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
8. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
9. Oxygenation predicts radiation response and survival in patients with cervix cancer
10. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using immunodetection
11. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: Analysis of drug adducts by fluorescent antibodies vs. bound radioactivity
12. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H tumors
13. Diffusion limited hypoxia estimated by vascular image analysis: Comparison with pimonidazole staining in human tumors
14. Detection of hypoxia in human squamous cell carcinoma by EF5 binding
15. Development of a hypoxia-responsive vector for tumor-specific gene therapy
16. Hypoxia-inducible regulation of a prodrug activating enzyme for tumor-specific gene therapy
17. SR 4233 (tirapazamine): A new anticancer drug exploiting hypoxia in solid tumours
18. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts
19. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells
20. Improved green fluorescence
21. Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX
22. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells
23. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinoma
24. Oxygen(es) and the hypoxia-inducible factor-1
25. 2 homeostasis by hypoxia-inducible factor 1
26. 2 tension
27. A rapid-mixing comparison of the mechanisms of radiosensitization by oxygen and misonidazole in CHO cells
28. m for radiosensitization at 0 degrees C of thiol depletion by diethylmaleate pretreatment: Quantitative differences found using the radiation sensitizing agent misonidazole or oxygen
29. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix